ESM1 and neoplasm: Recently, many microarray and substractive hybridization analyses of the gene expression profiles in several human cancers have identified endocan as being one of the genes defining a tumor signature, associated with poor prognosis with an increased risk of death or invasive disease in melanoma, breast, kidney prostate and lung cancers, [18-20,28,30].